DRKS00023322招募中不适用
Identification of biomarkers for prognosis of morbidity and mortality of SARS-CoV-2 (COVID-19) patients - COVID-19 biomarker
niversitätsklinikum Münster0 个研究点目标入组 250 人开始时间: 2020年10月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •confirmed COVID-19 infection
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Cohorts for patients with acute leukemiaNeoplasmsKCT0007129The Catholic University of Korea, Seoul St. Mary's Hospital2,250
招募中
不适用
Cohort for biomarkers to predict prognosis and treatment response in acute leukemiaDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0002261The Catholic University of Korea, Seoul St. Mary's Hospital1,500
招募中
不适用
Identification of predictive biomarkers for treatment outcome in patients with advanced hepatocellular carcinomaDiseases of the digestive systemKCT0002264Yonsei University Health System, Severance Hospital100
已完成
不适用
Elucidation of biomarkers to predict the presence of coronary vulnerable plaqueJPRN-UMIN000009806agasaki University Graduate School of Biomedical Sciences200
已完成
不适用
Prospective study for predictive biomarkers and modified risk scoring model for venous thromboembolism in Japanese patients with unresectable or metastatic cancer.lung cancer, esophageal cancer, gastric cancer, biliary tract cancer, pancreatic cancer, colorectal cancerJPRN-UMIN000026826Clinical Research Center, Saga University Hospital240